Neutralizing antibodies from the rare convalescent donors elicited antibody-dependent enhancement of SARS-CoV-2 variants infection

Currently, neutralizing antibody and vaccine strategies have been developed by targeting the SARS-CoV-2 strain identified during the early phase of the pandemic. Early studies showed that the ability of SARS-CoV-2 RBD or NTD antibodies to elicit infection enhancement in vivo is still controversial....

Descripción completa

Detalles Bibliográficos
Autores principales: Mu, Song, Song, Shuyi, Hao, Yanan, Luo, Feiyang, Wu, Ruixin, Wang, Yi, Han, Xiaojian, Li, Tingting, Hu, Chao, Li, Shenglong, Shen, Meiying, Huang, Jingjing, Wang, Wang, Wang, Yingming, Jin, Aishun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627283/
https://www.ncbi.nlm.nih.gov/pubmed/36341247
http://dx.doi.org/10.3389/fmed.2022.952697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627283/
https://www.ncbi.nlm.nih.gov/pubmed/36341247
http://dx.doi.org/10.3389/fmed.2022.952697

Ejemplares similares